Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report ; volume:12 ; number:1 ; day:20 ; month:12 ; year:2024 ; pages:1-8 ; date:12.2024
Acta Neuropathologica Communications ; 12, Heft 1 (20.12.2024), 1-8, 12.2024
- Creator
-
Landvater, Ryan
Tripathy, Arushi
Nieblas-Bedolla, Edwin
Shao, Lina
Conway, Kyle
Al-Holou, Wajd
Ferris, Sean P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-024-01908-7
- URN
-
urn:nbn:de:101:1-2503012112582.014126151836
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Landvater, Ryan
- Tripathy, Arushi
- Nieblas-Bedolla, Edwin
- Shao, Lina
- Conway, Kyle
- Al-Holou, Wajd
- Ferris, Sean P.
- SpringerLink (Online service)
Other Objects (12)
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
Therapies for IDH-Mutant Gliomas
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
Therapies for IDH-Mutant Gliomas
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma